Type | Indexed | Publication . Mgi Jnum | J:320457 |
Publication . Citation | Nishio T, et al. (2021) Immunotherapy-based targeting of MSLN(+) activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis. Proc Natl Acad Sci U S A 118(29):e2101270118 |